Abstract
Prostate cancer is (PCa) the second leading cause of cancer death in males in the United State, with 174,650 new cases and 31,620 deaths estimated in 2019. It has been documented that epigenetic deregulation such as histone modification and DNA methylation contributes to PCa initiation and progression. EZH2 (enhancer of zeste homolog 2), the catalytic subunit of the Polycomb Repressive Complex (PRC2) responsible for H3K27me3 and gene repression, has been identified as a promising target in PCa. In addition, overexpression of other epigenetic regulators such as DNA methyltransferases (DNMT) is also observed in PCa. These epigenetic regulators undergo extensive post-translational modifications, in particular, phosphorylation. AKT, CDKs, PLK1, PKA, ATR and DNA-PK are the established kinases responsible for phosphorylation of various epigenetic regulators.
| Original language | English |
|---|---|
| Pages (from-to) | 606-613 |
| Number of pages | 8 |
| Journal | Genes and Diseases |
| Volume | 7 |
| Issue number | 4 |
| DOIs | |
| State | Published - Dec 2020 |
Bibliographical note
Publisher Copyright:© 2019 Chongqing Medical University
Funding
NIH R01 CA157429 (X. Liu), R01 CA192894 (X. Liu), R01 CA196835 (X. Liu), R01 CA196634 (X. Liu). The work was also partially supported by University of Kentucky Cancer Center (P30 CA177558). NIH R01 CA157429 (X. Liu), R01 CA192894 (X. Liu), R01 CA196835 (X. Liu), R01 CA196634 (X. Liu). The work was also partially supported by University of Kentucky Cancer Center ( P30 CA177558 ).
| Funders | Funder number |
|---|---|
| National Institutes of Health (NIH) | R01 CA192894, R01 CA196835, R01 CA196634, R01 CA157429 |
| University of Kentucky Markey Cancer Center | P30 CA177558 |
Keywords
- DNMT
- EZH2
- Epigenetics
- HDAC
- Phosphorylation
- Prostate cancer
ASJC Scopus subject areas
- Biochemistry
- Molecular Biology
- Genetics(clinical)
- Cell Biology
